Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist trigger with versus without HCG in women with polycystic ovary syndrome undergoing IVF/ICSI
IRCT20180708040381N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in infertility and polycystic ovary syndrome (PCOS) comparing Decapeptyl + hCG with Decapeptyl alone (2 arms). Primary endpoints: Number of mature oocytes, Number of retrieved oocytes and 1 more. Started May 2024; status: completed.
02
Drugs
triptorelinhuman chorionic gonadotropin
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20180708040381N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180708040381N4.